Navigation Links
Deadline Approaches for ISPE Drug Shortage Survey
Date:3/13/2013

TAMPA, Fla., March 13, 2013 /PRNewswire-USNewswire/ -- ISPE announced today that the deadline is approaching for pharmaceutical professionals and companies to participate in the Society's global survey on drug shortages. Responses to the survey are due by 20 March 2013.

(Logo: http://photos.prnewswire.com/prnh/20120912/DC73253LOGO)

ISPE initially announced the survey in mid-February as part of its Drug Shortage Initiative, a global effort led by a task force of industry leaders with review and input by leading global health authorities and related organizations. ISPE launched this initiative in support of the pharmaceutical industry and global health authorities' efforts to understand and address the complex and critical issue of drug shortages. The survey is designed to collect data on the technical, scientific, manufacturing, quality and compliance issues that may have resulted in drug shortages.

"We are reaching out to pharmaceutical professionals and ISPE Members who have had experience dealing with technical, quality and manufacturing issues related to drug shortages, as well as those who have worked to avoid a shortage or who have never experienced a shortage but have been personally affected by a shortage situation," said ISPE President and CEO Nancy S. Berg . "This much-needed technical data will yield new insights into a critical global health issue."

ISPE is encouraging responses from both individuals and companies. Survey responses will be completely anonymous, and all data will be tabulated by a third-party firm. Results are expected to be announced and discussed at ISPE's Redefining the "C" in "CGMP" Conference in Baltimore, Md. USA, 11 – 13 June 2013.

For more information on this important initiative, please visit www.ISPE.org/DrugSurveyDetails.

About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.

For more information contact:

Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Obama Victory Reinforces Need for Insurers to Prepare for Healthcare Exchange 2013 and 2014 Deadlines
2. As Deadline Approaches, Practice Fusion Shares Meaningful Use Stories
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In American Oriental Bioengineering Inc. To Contact The Firm Regarding The August 22, 2012 Lead Plaintiff Deadline
4. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
5. Developers: Deadline Approaching for Allscripts Million Hearts CDS Challenge
6. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
7. Janssen Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
8. Businessmen Bank on Marijuana as Colorados Green Rush Approaches in the Medical Marijuana Industry with Hemp, Inc. (OTC: HEMP) Leading the Charge
9. As Prescription Painkiller Overdoses Mount, Researchers Outline Effective Approaches to Curb Epidemic
10. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
11. Survey of Oncologists Reveals 98.9% of Physicians Experienced Cancer Drug Shortages in Last 12 Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, Inc. ... technology solutions to improve the clinical effectiveness and ... for the first quarter ended March 31, 2017. ... enable our customers to identify when preventive care ... before events like heart attacks or strokes occur," ...
(Date:5/6/2017)... --  Provista , a proven leader in the supply chain ... Jim Cunniff as the company,s new president and ... to Provista, including most recently serving as the president and ... . He assumed his new role with Provista on May ... Provista," says Jody Hatcher , president, Sourcing and Collaboration ...
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
Breaking Medicine Technology:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... background. Understanind and choosing the most appropriate instruments for research and understanding the ... research finding. This webinar will focus on innovations in stereo microscopy for brightfield ...
(Date:5/24/2017)... ... , ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming ... referral. Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on ... no longer need to feel the esthetic effects of wires and brackets when they ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... reproductive tract in which the endometrial lining of the uterus spreads into ... pain. Patients experiencing painful intercourse, painful periods, pelvic pain, or irregular bleeding ...
(Date:5/24/2017)... ... May 24, 2017 , ... Rob Lowe is a ... developed for Public Television. “Informed” brings the public important topics from all aspects of ... of the feet and issues surrounding feet and ankles. , Podiatry is essential to ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
Breaking Medicine News(10 mins):